Stonecroft Capital Research
Advisory Approach & Positioning
Stonecroft Capital is a premier middle-market investment bank founded in 2001 and headquartered in Bethesda, Maryland, with a strategic global presence across Silicon Valley, Boulder, Washington D.C., Atlanta, and Dubai. The firm's core thesis centers on the "creation and harvest of value" for growth-oriented companies with significant potential. Unlike large, generalist investment banks that struggle to serve middle-market clients effectively, Stonecroft positions itself as an independent advisory boutique with deep industry expertise and a commitment to senior-level attention on every engagement.
The firm's competitive advantage stems from three core differentiators: (1) an unusually senior and multidisciplinary team that has demonstrated sustained excellence for over two decades, (2) extensive real-world operational experience beyond pure investment banking, and (3) deep, broad industry contacts combined with unique market intelligence that informs strategic decisions. By maintaining independence, Stonecroft eliminates many of the conflicts that plague larger banks and provides unbiased advice that prioritizes client outcomes above institutional interests.
Sector & Industry Expertise
Stonecroft's advisory practice spans six primary industry verticals, each led by a specialized group:
Technology Group (Led by Co-Founder Charles Cozean): The firm advises on enterprise software, communications, Internet and mobile platforms, semiconductors, electronics, and advanced materials. Cozean brings 25+ years of technology investment banking experience combined with operational background as an engineer at NASA and collaborative roles with General Motors, Bell Labs, and Intel. The Technology Group handles buy-side and sell-side M&A, recapitalizations, spin-outs, cross-border joint ventures, and licensing arrangements.
Healthcare Group (Led by Tim Howard): With 30 years of healthcare and M&A experience, Howard brings uncommon operational insight as a former CEO of Galt Associates (a bioinformatics firm subsequently acquired by Cerner Corporation). The Healthcare Group advises on pharmaceutical, medical device, contract research, healthcare technology, and emerging biotech transactions. Howard's experience raising venture capital and executing strategic exits provides deep empathy for emerging growth healthcare companies facing capital formation and exit decisions.
Energy & Renewables Group (Led by Steve Rhoades): Rhoades' background as CEO and COO of two market-leading public solar companies (Satcon Technology and Advanced Energy) gives the firm exceptional operational credibility in clean energy. The group advises on utility-scale solar, wind, energy efficiency, grid modernization, and related infrastructure. Rhoades has led companies through rapid scaling (growing Satcon from $24M to $188M revenue in 3 years and achieving #1 market share in North America for utility-scale photovoltaic inverters).
Digital Media & E-Learning Group (Led by Hala Suleiman): Based in Dubai with 15+ years of investment banking experience, Suleiman has built Stonecroft's transaction capability in digital media, entertainment, and e-learning sectors while serving as a bridge for clients seeking international partnerships and overseas opportunities.
Environmental & Safety Group (Led by John Wagner): Wagner brings 30+ years of experience in building business opportunities and leading strategic transactions, with deep expertise in environmental technologies, water/wastewater treatment, oil and gas, and food and beverage safety. Wagner holds 6 issued U.S. patents and serves on multiple advisory boards.
Emerging Technologies Group (Led by Michael Levi): With 20+ years launching companies across renewable energy, smart cities, mobile telecom, supply chain management, and enterprise software, Levi brings proven expertise in disruptive technologies. He previously helped launch Enphase Energy (NASDAQ: ENPH) into commercial solar markets and coordinated the SunPower/Cogenra acquisition and other significant transactions.
Process & Service Offerings
Stonecroft delivers a comprehensive suite of strategic advisory and transaction services:
- Merger & acquisition advisory for buyers, sellers, and corporate parents
- Project financing advisory
- Partnering advisory (joint ventures, technology licensing, distribution partnerships)
- Corporate divestitures, spin-outs, and management buyouts
- Fairness opinions and valuations
- Turnaround and strategic business analysis
The firm follows a disciplined three-phase engagement model: (1) Analysis—deeply understanding the client's situation, needs, and strategic objectives; (2) Strategy—developing and iterating on alternatives that often significantly shift client perspective; and (3) Execution—providing active leadership across all implementation aspects. Senior partners remain actively involved in every engagement, rejecting the common boutique practice of client-facing seniors paired with junior execution teams.
Client Track Record
Stonecroft has completed hundreds of corporate transactions and strategic projects since its 2001 founding. Notable transaction experience includes:
-
SurModics/Brookwood Pharmaceuticals (2007): Represented Southern Research Institute on the sale of Brookwood Pharmaceuticals (drug delivery technology) to SurModics for $40 million in cash plus up to $22 million in earnout. The transaction highlighted the firm's capability in healthcare technology M&A and asset spin-off scenarios.
-
November Research Group/HighPoint Solutions (2016): Served as exclusive financial advisor to November Research on the sale of its pharmacovigilance services division to HighPoint Solutions. The transaction enabled NRG's team to join a larger platform while maintaining specialized focus.
While Stonecroft's transactions page indicates "hundreds of completed transactions," the firm practices discretion regarding public deal disclosure, a common approach among independent boutiques serving private middle-market companies.
Geographic Coverage & Deal Size
Stonecroft operates across key U.S. markets (Midwest, Southeast, Texas, California) and has expanded internationally through its Dubai office. The firm typically serves companies with enterprise values in the $10M to $250M+ range, with particular depth in the $25M-$150M sweet spot where large banks are indifferent but smaller boutiques lack the resources.
Independence & Integrity
The firm explicitly emphasizes independence as a core operating principle. Stonecroft's business model—pure advisory without proprietary trading, principal investing, or private equity fund management—eliminates the conflicts that compromise larger banks' objectivity. This positioning resonates with growth companies and private sellers who require unbiased strategic counsel.
Team Quality & Continuity
A defining characteristic of Stonecroft is its commitment to senior-only engagement teams. Charles Cozean, Tim Howard, Steve Rhoades, Hala Suleiman, John Wagner, and Michael Levi collectively bring over 150 years of combined experience across technology, healthcare, energy, and emerging technologies. The firm's website explicitly states it is "actively seeking to expand senior staff in key markets" while "limiting its search to very senior investment bankers," reflecting a deliberate strategy of quality over scale.